Randomisation in clinical trials

Beller, Elaine M; Gebski, Val; Keech, Anthony C

doi:10.5694/j.1326-5377.2002.tb04955.x

Topics

Statistics, epidemiology and research design

Randomisation is the process of assigning clinical trial participants to treatment groups. Randomisation gives each participant a known (usually equal) chance of being assigned to any of the groups. Successful randomisation requires that group assignment cannot be predicted in advance.

1 Queensland Clinical Trials Centre, University of Queensland, Herston, QLD.
2 NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW.

Correspondence: enquiry@ctc.usyd.edu.au

1. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. Ann Intern Med 2001; 134: 657-662.
2. Keech A. Random allocation. Introduction to clinical trials. Clinical trials research methodology. Statistical methods in clinical trials. The ICH GCP guidelines. Hong Kong: The Clinical Trials Centre, 1998.
3. Pocock S. Clinical trials. A practical approach. New York: John Wiley, 1984.
4. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412.
5. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-613.
6. Gebski V, Beller E, Keech AC. Randomised trials: elements of a good study. Med J Aust 2001; 175: 272-274.

Online responses are no longer available. Please refer to our instructions for authors page for more information.